Report #2866209

Received Oct 16, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 56 yrs
State: NE
Recovered: Not recovered
Vaccinated: Oct 9, 2025
Onset: Oct 9, 2025
Days to onset: 0
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
PPV	PNEUMO (NO BRAND NAME)	UNKNOWN MANUFACTURER	UNK	UNK	LA
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	LA

Symptoms (1)

Nausea

Symptom narrative

Nausea; This non-serious case was reported by a consumer via call center representative and described the occurrence of nausea in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Pneumococcal vaccine for prophylaxis. Concurrent medical conditions included asthma. On 09-OCT-2025, the patient received Shingrix (left arm) and Pneumococcal vaccine (left arm). On 09-OCT-2025, 30 min after receiving Shingrix and Pneumococcal vaccine, the patient experienced nausea (Verbatim: Nausea). The outcome of the nausea was not resolved. It was unknown if the reporter considered the nausea to be related to Shingrix and Pneumococcal vaccine. It was unknown if the company considered the nausea to be related to Shingrix and Pneumococcal vaccine. Additional Information: GSK Receipt date: 09-OCT-2025 The patient received Shingrix and pneumonia vaccine on the same day in left arm. The patient did not have name of the Pneumonia vaccines. About 30 minutes after given the vaccine, the patient experienced nausea.

Current illness

Asthma